FierceBiotech ٤ مارس ٢٠٢٦ Pfizer's oncology R&D strategy: Jeff Legos on speed, breadth and novel combinations
FierceBiotech ٢٥ فبراير ٢٠٢٦ After gene therapy exit, Pfizer locks in global license for Beam gene editing candidate
Endpoints News ٢٤ فبراير ٢٠٢٦ Pfizer buys China rights to Sciwind’s approved GLP-1 drug in metabolic push
Endpoints News ٧ فبراير ٢٠٢٦ The Hims vs. Novo showdown; Pfizer’s monthly GLP-1 data; Q4 earnings roundup; and more
FierceBiotech ٦ فبراير ٢٠٢٦ Pfizer-backed Priovant scores again with fast-rising brepocitinib in midstage study
BioPharma Dive ٤ فبراير ٢٠٢٦ Earnings roundup: Amgen vs. FDA, Pfizer’s defense and Merck’s $70B-in-sales plan
FierceBiotech ٤ فبراير ٢٠٢٦ Novo's CEO 'wishes Pfizer luck' with Metsera drug, but still seeks own monthly GLP-1
FierceBiotech ٢١ يناير ٢٠٢٦ Pfizer CEO lays blame for US vaccine woes on RFK Jr.'s 'anti-science' stance: WSJ
BioPharma Dive ١٢ يناير ٢٠٢٦ JPM26: US biotech’s ‘Sputnik moment,’ Pfizer’s obesity ambitions and Bristol Myers’ big year
FierceBiotech ٩ يناير ٢٠٢٦ Madrigal pays $50M for Pfizer MASH drug with eye on Rezdiffra combo potential
Endpoints News ٨ يناير ٢٠٢٦ French biotech Enodia gets €20.7M aided by Pfizer for protein degrader work
FierceBiotech ٩ ديسمبر ٢٠٢٥ Pfizer continues renewed obesity push with $150M upfront for Fosun unit's GLP-1 drug